Syringe and Needle Market Forecast till 2027

$4,950$7,250

The global Syringe and Needle Market is expected to register substantial market growth during the review period.

SKU: MRFR220268 Category: Tag:

Description

Syringe and Needle Market forecast till 2027

Market Overview
The global Syringe and Needle Market is expected to register substantial market growth during the review period. A syringe is a pipe-like structure with a plunger that is connected to a needle. Plungers are exclusively used to be pushed into the barrel or a tube. The syringe is used to inject or take out fluid. They have particularly applied healthcare industry worldwide.

Nowadays syringes are available in the form of plastic cylinders and calibrated glass. The hypodermic needle and syringe are sterile gadgets that are utilized significantly for infusing arrangements or pulling out certain discharges to/from the body. The plunger is connected to the top end, while a needle is joined to the base finish of the tip.

Normally, a metal cylinder with a sharp tip, called a needle, is joined to syringes for doing a necessary purpose. Prominently syringes and needles are used to direct medications or infuse of few medications into a human body.

It is generally suggested when the patient can’t burn through the medication by mouth. Aside from that, the syringe and needle are likewise ideal for drawing or gathering tests of various blood liquids with the end goal of lab tests and conclusions. The tissue liquids from joints or blood from the veins are separated for lab tests.

The major market driver is a huge demand for the manufacturing of needles and syringes across the globe. Also, the technological advancements in the 23-gauge needle and syringe drug injecting system are expected to boost the global market during the review period. Additionally, the growing need for injectable drugs is proven to be a better substitute for oral drugs.

The clinics and hospitals consume a large number of syringes and needles every single day. However, the major market restraint is the use of syringes and needles gives rise to high infection risk.

Market Segmentation
The global syringe and needle market has been categorized into type, application type, end-user, and region.

Based on type segment, the global market has been classified into Blood collection syringe and needles, Bone marrow syringe and needles, Dental syringe and needles, Catheter syringe and needles, Epidural syringe and needles, and Ophthalmic syringe and needles.

In terms of application, the market is segmented into Diagnostic, General Surgery, Orthopaedics, Respiratory, Dental, Cardiovascular, and Neurology.
The Material Type segment divides the syringe and needle market into Disposable and Reusable.

By End User, the market has been classified into Diagnostic centers, Home Care, and Hospitals & Clinics.

Regional analysis
Geographically, the global syringe and needle market has been divided into Asia-Pacific, Europe, North America, and the Rest of the world.
Europe and the Asia Pacific contribute the largest market share of the global syringes and needles market owing to the highest production in the previous years.

Major Players
The prominent players for the global syringe and needle market include DeRoyal, Terumo Corporation, B.Braun Melsungen AG, Albert David Ltd, Septodont, Connecticut Hypodermics Inc., Medtronic, Cardinal Health, Schott AG, and Smiths Medical.

COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries.

Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

Additional information

Publisher

Geography Covered

Date Published

Pages

Format

Table of Contents

TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 SCOPE OF THE STUDY
2.2 RESEARCH OBJECTIVE
2.3 MARKET STRUCTURE
2.4 ASSUMPTIONS & LIMITATIONS
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 INCREASING PREVALENCE OF CHRONIC DISEASES
4.2.2 RAPID TECHNOLOGICAL ADVANCEMENTS
4.2.3 INCREASING GERIATRIC POPULATION
4.3 RESTRAINTS
4.3.1 INCREASED RISK OF NEEDLE STICK INJURIES
4.3.2 AVAILABILITY OF ALTERNATIVE ROUTE OF ADMINISTRATION
4.4 OPPORTUNITIES
4.4.1 GROWING NUMBER OF HOSPITALS AND CLINICS
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 DATA ACQUISITION
5.1.2 DATA ANALYSIS
5.1.3 DATA CURATION
5.1.4 DATA STORAGE
5.1.5 DATA USAGE
5.2 PORTER’S FIVE FORCES MODEL
5.2.1 BARGAINING POWER OF SUPPLIERS
5.2.2 BARGAINING POWER OF BUYERS
5.2.3 THREAT OF NEW ENTRANTS
5.2.4 THREAT OF SUBSTITUTES
5.2.5 INTENSITY OF RIVALRY
5.3 COVID-19 IMPACT ANALYSIS
5.3.1 DEMAND SUPPLY ANALYSIS
5.3.2 PRICING ANALYSIS
5.3.4 IMPACT ON RAW MATERIALS
5.3.5 IMPACT ON SUPPLY CHAIN
6 GLOBAL SYRINGE AND NEEDLE MARKET, BY TYPE
6.1 OVERVIEW
6.2 BLOOD COLLECTION SYRINGE AND NEEDLES
6.3 BONE MARROW SYRINGE AND NEEDLES
6.4 OPHTHALMIC SYRINGE AND NEEDLES
6.5 CATHETER SYRINGE AND NEEDLES
6.6 EPIDURAL SYRINGE AND NEEDLES
6.7 DENTAL SYRINGE AND NEEDLES
6.8 BLOOD COLLECTION SYRINGE AND NEEDLES
7 GLOBAL SYRINGE AND NEEDLE MARKET, BY APPLICATION
7.1 OVERVIEW
7.2 DIAGNOSTIC
7.3 GENERAL SURGERY
7.4 ORTHOPEDICS
7.5 RESPIRATORY
7.6 DENTAL
7.7 CARDIOVASCULAR
7.8 NEUROLOGY
8 GLOBAL SYRINGE AND NEEDLE MARKET, BY MATERIAL TYPE
8.1 OVERVIEW
8.2 DISPOSABLE
8.3 REUSABLE
9 GLOBAL SYRINGE AND NEEDLE MARKET, BY END USER
9.1 OVERVIEW
9.2 DIAGNOSTIC CENTERS
9.3 HOME CARE
9.4 HOSPITALS & CLINICS
10 GLOBAL SYRINGE AND NEEDLE MARKET, BY REGION
10.1 OVERVIEW
10.2 NORTH AMERICA
10.2.1 US
10.2.2 CANADA
10.3 EUROPE
10.3.1 GERMANY
10.3.2 FRANCE
10.3.3 UK
10.3.4 ITALY
10.3.5 SPAIN
10.3.6 REST OF EUROPE
10.4 ASIA-PACIFIC
10.4.1 CHINA
10.4.2 INDIA
10.4.3 JAPAN
10.4.4 AUSTRALIA
10.4.5 SOUTH KOREA
10.4.6 REST OF ASIA-PACIFIC
10.5 REST OF THE WORLD
10.5.1 MIDDLE EAST
10.5.2 AFRICA
10.5.3 LATIN AMERICA
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 COMPETITIVE BENCHMARKING
11.3 MAJOR GROWTH STRATEGY IN THE GLOBAL SYRINGE AND NEEDLE MARKET
11.4 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL SYRINGE AND NEEDLE MARKET
11.5 KEY DEVELOPMENT ANALYSIS
11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
11.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL
11.6.2 MERGER/ACQUISITION
11.6.3 PARTNERSHIP/AGREEMENT
11.6.4 EXPANSION
12 COMPANY PROFILES
12.1 TERUMO CORPORATION
12.1.1 COMPANY OVERVIEW
12.1.2 FINANCIAL OVERVIEW
12.1.3 PRODUCTS/SERVICES OFFERED
12.1.4 KEY DEVELOPMENTS
12.1.5 SWOT ANALYSIS
12.1.6 KEY STRATEGIES
12.2 B.BRAUN MELSUNGEN AG
12.2.1 COMPANY OVERVIEW
12.2.2 FINANCIAL OVERVIEW
12.2.3 PRODUCTS/SERVICES OFFERED
12.2.4 KEY DEVELOPMENTS
12.2.5 SWOT ANALYSIS
12.2.6 KEY STRATEGIES
12.3 ALBERT DAVID LTD
12.3.1 COMPANY OVERVIEW
12.3.2 FINANCIAL OVERVIEW
12.3.3 PRODUCTS/SERVICES OFFERED
12.3.4 KEY DEVELOPMENTS
12.3.5 SWOT ANALYSIS
12.3.6 KEY STRATEGIES
12.4 SEPTODONT
12.4.1 COMPANY OVERVIEW
12.4.2 FINANCIAL OVERVIEW
12.4.3 PRODUCTS/SOLUTIONS/SERVICES OFFERED
12.4.4 KEY DEVELOPMENTS
12.4.5 SWOT ANALYSIS
12.4.6 KEY STRATEGIES
12.5 CONNECTICUT HYPODERMICS INC.
12.5.1 COMPANY OVERVIEW
12.5.2 FINANCIAL OVERVIEW
12.5.3 PRODUCTS/SOLUTIONS/SERVICES OFFERED
12.5.4 KEY DEVELOPMENTS
12.5.5 SWOT ANALYSIS
12.5.6 KEY STRATEGIES
12.6 MEDTRONIC
12.6.1 COMPANY OVERVIEW
12.6.2 FINANCIAL OVERVIEW
12.6.3 PRODUCTS/SOLUTIONS/SERVICES OFFERED
12.6.4 KEY DEVELOPMENTS
12.6.5 SWOT ANALYSIS
12.6.6 KEY STRATEGIES
12.7 CARDINAL HEALTH
12.7.1 COMPANY OVERVIEW
12.7.2 FINANCIAL OVERVIEW
12.7.3 PRODUCTS/SOLUTIONS/SERVICES OFFERED
12.7.4 KEY DEVELOPMENTS
12.7.5 SWOT ANALYSIS
12.7.6 KEY STRATEGIES
12.8 SCHOTT AG
12.8.1 COMPANY OVERVIEW
12.8.2 FINANCIAL OVERVIEW
12.8.3 PRODUCTS/SERVICES OFFERED
12.8.4 KEY DEVELOPMENTS
12.8.5 SWOT ANALYSIS
12.8.6 KEY STRATEGIES
12.9 SMITHS MEDICAL
12.9.1 COMPANY OVERVIEW
12.9.2 FINANCIAL OVERVIEW
12.9.3 PRODUCTS/SOLUTIONS/SERVICES OFFERED
12.9.4 KEY DEVELOPMENTS
12.9.5 SWOT ANALYSIS
12.9.6 KEY STRATEGIES
12.10 DEROYAL
12.10.1 COMPANY OVERVIEW
12.10.2 FINANCIAL OVERVIEW
12.10.3 PRODUCTS/SOLUTIONS/SERVICES OFFERED
12.10.4 KEY DEVELOPMENTS
12.10.5 SWOT ANALYSIS
12.10.6 KEY STRATEGIES
13 APPENDIX
13.1 REFERENCES
13.2 RELATED REPORTS

Companies Mentioned

DeRoyal, Terumo Corporation, B.Braun Melsungen AG, Albert David Ltd, Septodont, Connecticut Hypodermics Inc., Medtronic, Cardinal Health, Schott AG, and Smiths Medical

Reviews

There are no reviews yet.

Be the first to review “Syringe and Needle Market Forecast till 2027”

[class^="wpforms-"]
[class^="wpforms-"]